Health
Recurrent GBM brain tumors with few mutations respond best to immunotherapy – Duke Department of Neurology
Glioblastoma brain tumors are especially perplexing.
Glioblastoma brain tumors are especially perplexing. Inevitably lethal, the tumors occasionally respond to new immunotherapies after theyve grown back, enabling up to 20% of patients to live well beyond predicted survival times.
What causes this effect has long been the pursuit of researchers hoping to harness immunotherapies to extend more lives.
New insights from a team led by Dukes Preston Robert Tisch Brain Tumor Center, including the Neurology Department’s Katherine Peters, MD, PhD, Dina Randazzo,…
-
Noosa News11 hours agoThe Best Things to Do in Brisbane This New Year’s Eve
-
General10 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
General20 hours agoThe Billion Dollar Balcony. ASIO’s sovereignty failure
-
General8 hours agoIncreased police powers begin at Adelaide Oval Ashes Test following Bondi attacks